Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3168
Source ID: NCT00060931
Associated Drug: Carvedilol
Title: Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypertension
Interventions: DRUG: carvedilol|DRUG: metoprolol
Outcome Measures: Primary: Change from baseline in HbA1c at 5 months, 5 months | Secondary: Blood pressure at 3 and 5 months Body weight at 3 and 5 months Lab levels (glucose, insulin, triglycerides, cholesterol, and albumin:creatinine ratio) at 3 and 5 months., 5 months
Sponsor/Collaborators: Sponsor: GlaxoSmithKline
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 501
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2001-06
Completion Date: 2004-04
Results First Posted:
Last Update Posted: 2015-04-14
Locations: GSK Investigational Site, Birmingham, Alabama, 35211, United States|GSK Investigational Site, Birmingham, Alabama, 35294-0012, United States|GSK Investigational Site, Birmingham, Alabama, 35294-2041, United States|GSK Investigational Site, Columbia, Alabama, 35051, United States|GSK Investigational Site, Mobile, Alabama, 36608, United States|GSK Investigational Site, Derby, Connecticut, 06418, United States|GSK Investigational Site, Farmington, Connecticut, 06030 - 1410, United States|GSK Investigational Site, Hartford, Connecticut, 06106, United States|GSK Investigational Site, New Britain, Connecticut, 06050, United States|GSK Investigational Site, Newark, Delaware, 19713, United States|GSK Investigational Site, Washington, District of Columbia, 20037, United States|GSK Investigational Site, Washington, District of Columbia, 20422, United States|GSK Investigational Site, Coral Gables, Florida, 33134, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33308, United States|GSK Investigational Site, Fort Lauderdale, Florida, 33316, United States|GSK Investigational Site, Fort Meyers, Florida, 33907, United States|GSK Investigational Site, Gainesville, Florida, 32605, United States|GSK Investigational Site, Hollywood, Florida, 33021, United States|GSK Investigational Site, Hollywood, Florida, 33023, United States|GSK Investigational Site, Inverness, Florida, 34452, United States|GSK Investigational Site, Jacksonville, Florida, 32205, United States|GSK Investigational Site, Jacksonville, Florida, 32216, United States|GSK Investigational Site, Melbourne, Florida, 32901, United States|GSK Investigational Site, Miami, Florida, 33133, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Miami, Florida, 33156, United States|GSK Investigational Site, Miami, Florida, 33176, United States|GSK Investigational Site, Ocala, Florida, 34471, United States|GSK Investigational Site, Ocala, Florida, 34474, United States|GSK Investigational Site, Pembroke Pines, Florida, 33024, United States|GSK Investigational Site, Saint Petersberg, Florida, 33705, United States|GSK Investigational Site, Sarasota, Florida, 34239, United States|GSK Investigational Site, Tamarac, Florida, 33321, United States|GSK Investigational Site, Tampa, Florida, 33614, United States|GSK Investigational Site, Augusta, Georgia, 30901, United States|GSK Investigational Site, Fayetteville, Georgia, 30214, United States|GSK Investigational Site, Lawrenceville, Georgia, 30045, United States|GSK Investigational Site, Savannah, Georgia, 31406, United States|GSK Investigational Site, Chicago, Illinois, 60616, United States|GSK Investigational Site, West Evanston, Illinois, 60202, United States|GSK Investigational Site, Newburgh, Indiana, 47630, United States|GSK Investigational Site, Wabash, Indiana, 46992, United States|GSK Investigational Site, Lexington, Kentucky, 40508, United States|GSK Investigational Site, New Orleans, Louisiana, 70112, United States|GSK Investigational Site, New Orleans, Louisiana, 70121, United States|GSK Investigational Site, Auburn, Maine, 04210, United States|GSK Investigational Site, Bangor, Maine, 04401, United States|GSK Investigational Site, Baltimore, Maryland, 21204, United States|GSK Investigational Site, Baltimore, Maryland, 21208, United States|GSK Investigational Site, Ayer, Massachusetts, 01432, United States|GSK Investigational Site, Boston, Massachusetts, 02115, United States|GSK Investigational Site, Haverhill, Massachusetts, 01831-2451, United States|GSK Investigational Site, Springfield, Massachusetts, 01107, United States|GSK Investigational Site, Waltham, Massachusetts, 02453, United States|GSK Investigational Site, Worcester, Massachusetts, 01605, United States|GSK Investigational Site, Worcester, Massachusetts, 01610, United States|GSK Investigational Site, Waterford, Michigan, 48328, United States|GSK Investigational Site, Gulfport, Mississippi, 39501, United States|GSK Investigational Site, Camden, New Jersey, 08103, United States|GSK Investigational Site, Hackensack, New Jersey, 07601, United States|GSK Investigational Site, Linwood, New Jersey, 08221, United States|GSK Investigational Site, Margate, New Jersey, 08402, United States|GSK Investigational Site, Sea Girt, New Jersey, 08750, United States|GSK Investigational Site, Voorhees, New Jersey, 08043, United States|GSK Investigational Site, Bronx, New York, 10461, United States|GSK Investigational Site, Bronx, New York, 10467, United States|GSK Investigational Site, Buffalo, New York, 14209, United States|GSK Investigational Site, Flushing, New York, 11365, United States|GSK Investigational Site, Fulton, New York, 13069, United States|GSK Investigational Site, Kingston, New York, 12401, United States|GSK Investigational Site, Lancaster, New York, 14043, United States|GSK Investigational Site, Liverpool, New York, 13088, United States|GSK Investigational Site, New Hyde Park, New York, 11040, United States|GSK Investigational Site, New York, New York, 10021, United States|GSK Investigational Site, New York, New York, 10028, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, Rochester, New York, 14609, United States|GSK Investigational Site, Scarsdale, New York, 10583, United States|GSK Investigational Site, Syracuse, New York, 13202, United States|GSK Investigational Site, Tonawanda, New York, 14150, United States|GSK Investigational Site, Williamsville, New York, 14221, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Hickory, North Carolina, 28601, United States|GSK Investigational Site, Raleigh, North Carolina, 27609, United States|GSK Investigational Site, Statesville, North Carolina, 28677, United States|GSK Investigational Site, Wilmington, North Carolina, 28412, United States|GSK Investigational Site, Winston-Salem, North Carolina, 27103, United States|GSK Investigational Site, Canton, Ohio, 44708, United States|GSK Investigational Site, Cincinnati, Ohio, 45246, United States|GSK Investigational Site, Cleveland, Ohio, 44106, United States|GSK Investigational Site, Columbus, Ohio, 43212, United States|GSK Investigational Site, Zanesville, Ohio, 43701, United States|GSK Investigational Site, Camp Hill, Pennsylvania, 17011, United States|GSK Investigational Site, Connellsville, Pennsylvania, 15425, United States|GSK Investigational Site, Downington, Pennsylvania, 19335, United States|GSK Investigational Site, Erie, Pennsylvania, 16505, United States|GSK Investigational Site, Fleetwood, Pennsylvania, 19522, United States|GSK Investigational Site, Morrisville, Pennsylvania, 19067, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19107, United States|GSK Investigational Site, Philipsburgh, Pennsylvania, 16966, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15206, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15241, United States|GSK Investigational Site, West Grove, Pennsylvania, 19390, United States|GSK Investigational Site, Columbia, South Carolina, 29201, United States|GSK Investigational Site, Greer, South Carolina, 29651, United States|GSK Investigational Site, Summerville, South Carolina, 29485, United States|GSK Investigational Site, Bristol, Tennessee, 37620, United States|GSK Investigational Site, Jackson, Tennessee, 38301, United States|GSK Investigational Site, Memphis, Tennessee, 38163, United States|GSK Investigational Site, Nashville, Tennessee, 37212, United States|GSK Investigational Site, White River Junction, Utah, 05009, United States|GSK Investigational Site, Christiansburg, Virginia, 24073, United States|GSK Investigational Site, Falls Church, Virginia, 22044, United States|GSK Investigational Site, Fredericksburg, Virginia, 20401, United States|GSK Investigational Site, Richmond, Virginia, 23220, United States|GSK Investigational Site, Richmond, Virginia, 23294, United States|GSK Investigational Site, Salem, Virginia, 24153, United States|GSK Investigational Site, Springfield, Virginia, 22151, United States
URL: https://clinicaltrials.gov/show/NCT00060931

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D337 Carvedilol small molecule DB01136 Details